Clinical Trial Update: STA-4783 and Paclitaxel for Treatment of Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update reports results from a Phase 1 study evaluating STA-4783 in combination with Paclitaxel for solid tumors, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• STA-4783 (STA-4783)

Snippet

Sponsor: Synta Pharmaceuticals Corp. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED